• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

NRG Therapeutics

To add a bio or update company history, please click update information.

News from NRG Therapeutics

    NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapiesNRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
    NRG Therapeutics
    8 Sept 2025

    NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies

    NRG Therapeutics develops oral small-molecule drugs targeting mitochondrial dysfunction, aiming to slow or halt neurodegenerative diseases such as ALS and Parkinson’s through disease-modifying treatments.

NRG Therapeutics
  • Life Sciences
  • Stevenage, United Kingdom
  • £50m
  • nrgtherapeutics.com
  • Update Information

More venture news

  • Qureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
    Qureight
    29 Jul 2026

    Qureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease

    Series BLife Sciences
  • Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
    Healome Therapeutics
    7 Jul 2026

    Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease

    SeedLife Sciences
  • Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins
    Revolver Therapeutics
    6 Jul 2026

    Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins

    EquityLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn